New Swab Test Could Spare some Women a Painful Biopsy for Endometrial Cancer

Metrópoles

DOL - Diário Online

View article

Reposted by

DOL - Diário Online

Factuality

Ownership

Examination analyzes uterine cell genetic material in vaginal samples and is being studied with about 3,000 women in the United States

大纪元 Epoch Times

Factuality

Ownership

PinkDx, an American company, has developed a vaginal swab technology for detecting endometrial cancer. This technology analyzes DNA and RNA fragments to look for cancer signals, potentially reducing the need for invasive biopsies on women. Large-scale clinical trials are underway, with a launch expected as early as mid-2027.